FINEME / COMPANY INTELLIGENCE

Company Intelligence

See what changed in published company financial reports, follow the businesses you care about, and compare a small sample from the same industry. Figures are historical—not share prices or investment recommendations.

My World ↗Compare companies ↗

01 / MY COMPANY WATCHLIST

Your followed companies

Read the latest financial periods and filing-list dates saved for companies you follow in My World.

Manage in My World →

Loading followed companies…

Followed companies and last-check comparisons are kept in this browser only. A changed badge means stored information changed since this browser last checked, not that a new filing occurred at that moment.

02 / FIND A BUSINESS

Browse the company directory

Search by name, ticker or CIK. Browse all matching listings, including companies without available analysis.

AAGILENT TECHNOLOGIES, INC.

Inspect →

AAAlcoa Corp

Inspect →

AAAUGoldman Sachs Physical Gold ETF

Inspect →

AACAres Acquisition Corp III

Inspect →

AACGATA Creativity Global

Inspect →

AACIArmada Acquisition Corp. III

Inspect →

AACOAbony Acquisition Corp. I

Inspect →

AACPApogee Acquisition Corp

Inspect →

AADXApplied Aerospace & Defense, Inc.

Inspect →

AAGHAmerica Great Health

Inspect →

AALAmerican Airlines Group Inc.

Inspect →

AAMEATLANTIC AMERICAN CORP

Inspect →

03 / FINANCIAL CHANGES

Design Therapeutics, Inc. DSGN

Pharmaceutical Preparations · SIC 2834

Full analysis →

Latest standalone quarter

Period ending 2026-09-30

Filed: 2026-11-04 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2025-09-30.

Revenue0.00

USD million

Change year over year: 0.00

Net income-20.29

USD million

Change year over year: -3.29

Operating cash flow-15.38

USD million

Change year over year: -4.22

Total liabilities14.61

USD million

Change year over year: +2.56

Total assets216.81

USD million

Change year over year: +5.04

Liabilities / assets: 6.7% · Change: +1.0 percentage points

Open original filing ↗

Latest annual report

Period ending 2025-12-31

Filed: 2026-03-09 · Retrieved: 2026-11-05

Compared with the same period of the prior year, ending 2024-12-31.

Revenue0.00

USD million

Change year over year: 0.00

Net income-69.79

USD million

Change year over year: -20.20

Operating cash flow-54.36

USD million

Change year over year: -11.25

Total liabilities13.70

USD million

Change year over year: +3.70

Total assets226.20

USD million

Change year over year: -25.89

Liabilities / assets: 6.1% · Change: +2.1 percentage points

Open original filing ↗

04 / INDUSTRY CONTEXT

Other companies with the same SIC classification

A small, non-ranked sample of available annual reports. Periods and business models may differ.

Company	Period ending	Revenue (USD million)	Net margin	Operating cash margin
LYEL ↗	2025-12-31	0.04	-762,355.6%	-416,733.3%
RPRX ↗	2025-12-31	2,378.19	32.4%	104.7%
HRMY ↗	2025-12-31	868.45	18.3%	40.1%
ARQT ↗	2025-12-31	372.07	-4.3%	-1.5%
MIRM ↗	2025-12-31	521.31	-4.5%	10.7%
RCUS ↗	2025-12-31	33.00	-1,069.7%	-1,460.6%

Same SIC does not prove businesses are direct competitors. Annual periods may differ; margins may not be meaningful for every industry. Missing data are not zero and this is not a stock ranking.

05 / RECENT FINANCIAL RECORDS

Recently filed reports in the imported dataset

These are the newest filing dates found in the locally available annual and quarterly financial records. Not a real-time SEC feed; late imports and amended filings may affect what appears.

Latest standalone quarter

DSGN ↗

Design Therapeutics, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

OZ ↗

Belpointe PREP, LLC

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

LYEL ↗

Lyell Immunopharma, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

ADEA ↗

Adeia Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RPRX ↗

Royalty Pharma plc

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

HRMY ↗

Harmony Biosciences Holdings, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

RYM ↗

RYTHM, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

GTBIF ↗

Green Thumb Industries Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

SLQT ↗

SelectQuote, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

GTM ↗

ZoomInfo Technologies Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

ROOT ↗

Root, Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Latest standalone quarter

LIFE ↗

Ethos Technologies Inc.

Filed: 2026-11-04
Period ending: 2026-09-30

Interpret the evidence carefully

Company figures are historical, sometimes revised and not necessarily from the same period. This tool does not include live stock prices, valuation, a prediction of future performance, or guaranteed real-time filing alerts. Use source filings to verify decisions.

Data sources and methodology →